VIVUS to Present at Upcoming Investor Conference
MOUNTAIN VIEW, CA -- (Marketwired) -- 04/03/14 -- VIVUS, Inc.
(NASDAQ: VVUS) today announced that management will present an
overview of the company at the following investor conference:
13th Annual Needham Healthcare Conference
April 8, 2014, 3:40pm EDT
The Westin Grand Central Hotel, New York
A live webcast and 30-day archive of the presentation will be
available at http://ir.vivus.com.
VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in
obesity, sleep apnea, diabetes and sexual health. For more
information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within
the meaning of the Private Securities Litigation Reform Act of 1995.
These statements may be identified by the use of forward-looking
words such as "anticipate," "believe," "forecast," "estimate,"
"expect," "intend," "likely," "may," "plan," "potential," "predict,"
"opportunity" and "should," among others. There are a number of
factors that could cause actual events to differ materially from
those indicated by such forward-looking statements. VIVUS does not
undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in the
VIVUS Form 10-K for the year ending December 31, 2013, and periodic
reports filed with the Securities and Exchange Commission.
Dana B. Shinbaum
Corporate Development & Investor Relations
The Trout Group
Press spacebar to pause and continue. Press esc to stop.